These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2749586)

  • 1. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.
    Walley TJ; Woods KL; Barnett DB
    Thromb Haemost; 1989 Feb; 61(1):137-9. PubMed ID: 2749586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME; Renzulli LA
    Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
    Butt IF; Saeed SA; Waqar SN; Aslam M
    J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antithrombogenic in vivo effects of calcium channel blockers in experimental thrombosis in mice.
    Ortega MP; Sunkel C; Priego JG; Statkow PR
    Thromb Haemost; 1987 Jun; 57(3):283-5. PubMed ID: 3660330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
    Ivleva AIa; Kobalava ZhD; Moiseev VS
    Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx.
    Shah BH; Shamim G; Khan S; Saeed SA
    Biochem Mol Biol Int; 1996 May; 38(6):1135-41. PubMed ID: 8739035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
    Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
    Drugs Exp Clin Res; 1985; 11(9):645-51. PubMed ID: 3939725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
    J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
    Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
    Johnson GJ; Leis LA; Francis GS
    Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium entry blockers and human platelet aggregation.
    Gotta AW; Capuano C; Hartung J; Sullivan CA
    N Y State J Med; 1988 Mar; 88(3):132-3. PubMed ID: 3357613
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of calcium channel-blocking agents on platelet-osteogenic sarcoma interaction: platelet aggregation and electron microscopic findings.
    Mehta P; Kimura A; Lawson D
    J Orthop Res; 1990 Sep; 8(5):629-34. PubMed ID: 2388101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
    Vinge E; Andersson TL; Larsson B
    Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells.
    Hoffman S; Gopalakrishna R; Gundimeda U; Murata T; Spee C; Ryan SJ; Hinton DR
    Exp Eye Res; 1998 Jul; 67(1):45-52. PubMed ID: 9702177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.